Joseph C. Schick - 07 Oct 2021 Form 4 Insider Report for BIOLIFE SOLUTIONS INC (BLFS)

Role
Director
Signature
/s/ Joseph C. Schick
Issuer symbol
BLFS
Transactions as of
07 Oct 2021
Net transactions value
-$130,145
Form type
4
Filing time
12 Oct 2021, 20:00:30 UTC
Previous filing
27 Aug 2021
Next filing
10 May 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BLFS Common Stock Sale $25,175 -625 -5.3% $40.28 11,250 07 Oct 2021 Direct F1
transaction BLFS Common Stock Sale $25,050 -625 -5.6% $40.08 10,625 07 Oct 2021 Direct F1, F2
transaction BLFS Common Stock Sale $79,920 -2,000 -19% $39.96 8,625 07 Oct 2021 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.0801 to $40.0835, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.87 to $40.08, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.